No Data
No Data
Lake Street Initiates Organogenesis(ORGO.US) With Buy Rating, Announces Target Price $5
Lake Street analyst Brooks O'Neil initiates coverage on $Organogenesis(ORGO.US)$ with a buy rating, and sets the target price at $5.According to TipRanks data, the analyst has a success rate of 43.3%
Organogenesis Holdings Initiated at Buy by Lake Street
Organogenesis Holdings Initiated at Buy by Lake Street
Lake Street Initiates Coverage On Organogenesis Hldgs With Buy Rating, Announces Price Target of $5
Lake Street analyst Brooks O'Neil initiates coverage on Organogenesis Hldgs (NASDAQ:ORGO) with a Buy rating and announces Price Target of $5.
Organogenesis Hldgs Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/28/2024 92.31% Lake Street → $5 Initiates Coverage On → Buy 03/01/2024 92.31% Cantor Fitzgerald → $5 Re
Wound Skin Substitutes Market Global Analysis to 2030, Featuring Coloplast, Smith & Nephew, MTF Biologics, MiMedx, AlloSource, Organogenesis, RTI Surgical, LifeNet Health and Molecular Biologicals
With 38% Ownership, Organogenesis Holdings Inc. (NASDAQ:ORGO) Insiders Have a Lot Riding on the Company's Future